microarray
platform
widerang
potenti
biodef
owe
high
level
throughput
attain
miniatur
microarray
acceler
abil
respond
epidem
crisi
extend
beyond
diagnost
recent
studi
appli
microarray
research
tool
toward
understand
etiolog
pathogen
danger
pathogen
well
vaccin
develop
origin
emphasi
dna
microarray
rang
includ
protein
antibodi
carbohydr
microarray
research
group
exploit
divers
extend
microarray
applic
area
biodef
discuss
impact
contribut
grow
rang
microarray
emphas
concept
might
shape
futur
biodef
research
see
front
matter
natur
outbreak
wanton
use
pathogen
organ
act
terror
tremend
impact
human
popul
especi
consid
event
past
decad
modern
travel
trade
dissip
tradit
geograph
boundari
curb
spread
diseas
infecti
agent
capabl
spread
human
human
sever
acut
respiratori
syndrom
sar
coronaviru
shown
us
quickli
matter
week
threat
anywher
could
becom
threat
everywher
lesson
learnt
sar
avian
flu
anthrax
letter
attack
emphas
need
improv
prepared
respons
treatment
known
emerg
biolog
threat
also
prompt
heighten
fund
initi
worldwid
build
nation
intern
biodef
capabl
among
system
protocol
put
place
platform
facilit
rapid
accur
identif
agent
particularli
vital
confirm
whether
attack
occur
institut
prompt
measur
secur
public
health
intrins
abil
microarray
perform
multiplex
lowvolum
sensit
biolog
assay
highli
scalabl
manner
signific
advantag
biolog
threat
analysi
develop
earli
mid
dna
microarray
stir
technolog
revolut
continu
propel
genom
research
today
applic
includ
identif
comparison
mrna
dna
across
tissu
organ
hybrid
thousand
oligomer
dna
probe
immobil
planar
surfac
glass
slide
figur
provid
research
unpreced
abil
quantifi
genomewid
differ
gene
express
sequenc
chang
use
minim
amount
sampl
context
biodef
studi
dramat
extend
capabl
beyond
mere
detect
known
pathogen
abl
rapidli
profil
character
pathogen
well
identifi
novel
strain
genet
island
manifest
chang
virul
evolut
resist
compar
phylogenom
profil
use
microarray
facilit
understand
pathogen
diversif
provid
birdsey
view
gene
content
present
absent
within
given
microbi
genom
microarray
technolog
also
brought
outsid
laboratori
pointofcar
develop
widen
implic
threat
detect
dnabas
detect
system
gener
reli
abil
pcr
amplifi
fluoresc
tag
tini
amount
target
dna
present
specimen
advanc
miniatur
initi
pcr
step
instanc
develop
review
glossari
biodef
defens
measur
biolog
threat
includ
natur
emerg
pathogen
bioterror
agent
signific
potenti
endang
public
health
detect
identifi
presenc
target
pathogen
clinic
environment
sampl
diagnost
test
use
detect
medic
condit
exampl
test
caus
pathogen
respons
infect
sandwich
immunoassay
biochem
assay
detect
presenc
abund
target
substanc
use
antibodyantigen
reaction
two
antibodi
use
first
immobil
free
antibodi
carri
report
group
therebi
provid
posit
readout
target
recogn
sandwich
two
antibodi
sensit
probabl
posit
result
pathogen
inde
present
high
sensit
relat
low
type
error
serovar
group
microorgan
distinguish
presenc
specif
surfac
antigen
specif
probabl
neg
result
pathogen
present
high
specif
relat
low
type
error
tile
array
tile
array
type
dna
microarray
short
probe
segment
design
cover
entir
genom
use
extent
probe
overlap
translat
map
resolut
might
rang
highli
overlap
probe
across
individu
nucleotid
base
resequenc
applic
nonoverlap
probe
genomewid
express
analysi
vaccinia
viru
poxviru
close
relat
viru
caus
cowpox
first
human
vaccin
extens
use
vaccin
smallpox
correspond
author
uttamchandani
mahesh
dsoorgsg
micropcr
mpcr
follow
hybrid
identif
probe
dna
microarray
spunoff
viabl
chipbas
platform
abl
success
perform
biolog
threat
detect
analysi
portabl
system
describ
alreadi
appear
market
compet
attract
lucr
biodef
fund
altern
detect
platform
exploit
quantit
pcr
fieldabl
realtim
detector
posit
pcr
amplif
would
indic
presenc
correspond
target
dna
includ
devic
genexpert
cepheid
rapid
idaho
technolog
bioseeq
smith
detect
system
provid
rel
limit
throughput
microarray
system
contrast
definit
highli
scalabl
hundr
ten
thousand
possibl
dna
element
interrog
singl
experi
perform
nevertheless
hing
adopt
robust
panel
probe
accur
identifi
dna
organ
interest
success
extract
amplif
pathogen
dna
relev
clinic
sampl
isol
recent
develop
microarray
technolog
significantli
broaden
horizon
use
biodef
arena
well
beyond
confin
dnabas
profil
detect
newer
microarray
format
develop
turn
centuri
provid
host
biomolecul
present
chip
includ
protein
whole
proteom
enzym
antibodi
small
molecul
druglik
molecul
peptid
carbohydr
even
whole
cell
tissu
simultan
multiplex
experiment
format
offer
uniqu
way
microarray
har
toward
improv
understand
pathogen
biolog
figur
microarray
paradigm
year
contribut
significantli
toward
goal
provid
robust
tool
molecular
diagnost
also
advanc
biodef
capabl
protect
therapi
review
describ
microarraybas
applic
biodef
well
excit
new
concept
approach
drive
futur
advanc
growth
probe
select
design
usual
import
first
step
microarraybas
pathogen
detect
mani
issu
associ
probe
design
dna
microarray
impact
overal
fidel
assay
particular
regard
level
specif
sensit
attain
issu
consider
includ
crosshybrid
orthogon
probe
bind
target
dna
specif
organ
interest
vice
versa
uniform
anneal
temperatur
gc
content
probe
length
occurr
fals
posit
fals
neg
highli
problemat
might
caus
discuss
articl
dna
microarray
appli
test
dna
pathogen
organ
resequenc
pathogen
genom
b
antibodi
microarray
use
detect
pathogen
protein
antigen
might
present
environment
sampl
indic
contamin
diagnost
purpos
determin
pathogen
infect
human
tissu
c
smallmolecul
microarray
offer
novel
approach
differenti
pathogen
exampl
cluster
bind
signatur
obtain
pathogen
also
use
identifi
therapeut
could
potenti
disrupt
infect
cycl
trend
biotechnolog
vol
unwarr
respons
potenti
panic
miss
respons
lost
opportun
intervent
unaccept
deal
deadli
biolog
threat
reason
biodef
detect
platform
strive
reach
near
perfect
accuraci
compar
better
usual
goldstandard
assaystyp
culturebas
method
microarray
redund
howev
easili
engin
system
improv
accuraci
analyt
power
simpli
overrepresent
us
center
diseas
control
cdc
identifi
list
agent
spread
uncontrol
potenti
caus
major
public
health
crisi
heavi
morbid
mortal
rate
box
pathogen
subclassifi
categori
b
c
accord
degre
risk
impos
tabl
wilson
et
al
fabric
custom
affymetrix
microarray
contain
probe
detect
dna
amplifi
differ
pathogen
microorgan
simultan
includ
pathogen
us
cdc
list
bioterror
agent
bacillu
anthraci
caus
anthrax
clostridium
botulinum
gener
botulinum
toxin
yersinia
pesti
caus
bubon
plagu
ebola
viru
specif
multiplex
primer
set
design
amplifi
uniqu
diagnost
region
specif
organ
hybrid
tile
array
compris
probe
highli
redund
system
facilit
accur
identif
organ
test
probe
work
predict
impress
littl
fg
equival
mass
two
genom
dna
two
cell
b
anthraci
could
detect
multiplex
pcr
microarray
even
though
cultur
method
theori
abl
amplifi
detect
singl
organ
procedur
usual
timeconsum
challengingdetect
could
take
h
sever
day
depend
microb
type
even
longer
fastidi
microb
eg
mycobacterium
tuberculosisa
slow
grow
microb
might
requir
special
yet
undiscov
laboratori
growth
condit
molecular
identif
use
random
pcr
follow
multiplex
resolut
microarray
offer
particularli
attract
altern
detect
diagnost
gener
result
h
assay
optim
figur
wang
et
al
develop
microarray
approach
screen
viral
pathogen
across
broad
viral
famili
random
primer
use
amplifi
viral
rna
present
sampl
use
revers
transcriptasepcr
follow
hybrid
microarray
compris
probe
repres
nearli
viru
genom
degeneraci
probe
microarray
crosshybrid
certain
virus
across
expect
pattern
indic
emerg
novel
uncharacter
strain
could
henc
identifi
aid
microarray
similarli
sengupta
colleagu
develop
microarray
probe
distinguish
among
variou
influenza
virus
primer
design
characterist
sequenc
specif
influenza
target
viral
fusion
protein
haemagglutinin
glycosidas
neuraminidas
segment
use
affymetrix
respiratori
pathogen
microarray
lin
et
al
detect
respiratori
virus
influenza
adenoviru
differenti
accord
strain
speci
setup
made
use
socal
resequenc
microarray
contain
one
perfectli
match
three
mismatch
probe
per
base
thu
abl
identifi
genet
mutat
sequenc
level
array
larg
screen
capac
meant
forward
revers
strand
dna
target
could
sequenc
provid
ad
sequenc
accuraci
pool
primer
pair
also
optim
use
detect
dna
rna
target
pathogen
caus
upper
respiratori
tract
infect
includ
virus
influenza
corona
virus
other
bacteria
bordetella
pertusi
streptococcu
pyogen
other
small
subunit
ribosom
rna
ssu
rrna
gene
use
wide
microbi
marker
taxonomi
speci
classif
desanti
colleagu
gener
highdens
tile
microarray
oligonucleotid
probe
ssu
rrna
suffici
coverag
detect
differ
order
microb
environment
sampl
well
novel
variant
exhibit
mutat
ssu
rrna
array
fluoresc
intens
correl
well
spike
pathogen
concentr
provid
mean
quantifi
pathogen
box
bioterror
agent
classif
biohazard
agent
pose
signific
threat
requir
special
attent
especi
implement
regulatori
measur
control
limit
access
distribut
prevent
fall
wrong
hand
addit
measur
also
aim
rais
awar
within
nation
healthcar
system
amongst
healthcar
provid
especi
case
bioterror
threat
rare
seen
us
center
diseas
control
cdc
compil
list
biohazard
agent
divid
categori
b
c
accord
level
threat
impos
characterist
describ
exampl
pathogen
three
categori
provid
tabl
cdc
defin
categori
agent
highest
prioriti
biodef
research
organ
easili
dissemin
person
person
result
high
mortal
rate
potenti
caus
major
impact
public
health
accident
deliber
releas
agent
could
caus
public
panic
social
disrupt
agent
thu
requir
particular
attent
ensur
public
health
prepared
pose
signific
risk
nation
secur
cdc
defin
categori
b
agent
moder
easi
dissemin
pathogen
result
moder
morbid
low
mortal
agent
would
henc
requir
specif
improv
diagnost
capabl
well
enhanc
measur
diseas
surveil
cdc
defin
categori
c
agent
potenti
mass
dissemin
futur
avail
eas
product
dissemin
categori
also
includ
emerg
threat
potenti
caus
high
morbid
mortal
rate
well
major
impact
public
health
detail
classif
priorit
biolog
threat
agent
avail
cdc
websit
http
wwwbtcdcgovagentagentlistcategoryasp
level
origin
sampl
similar
method
use
detect
staphylococci
isol
taken
staphylococci
speci
correctli
assign
use
rrna
sequenc
microarray
confer
sensit
abil
refin
expand
exist
probe
set
exampl
incorpor
addit
inform
genet
loci
key
advantag
provid
dna
microarray
platform
increas
redund
henc
improv
assay
perform
fidel
miller
colleagu
appli
microarray
clinic
diagnost
abl
identifi
pathogen
panel
patient
specimen
accuraci
score
calcul
sensit
specif
microarray
design
detect
rna
virus
includ
sar
coronaviru
dengu
virus
use
probe
total
probe
replic
seven
print
nimblegen
tile
microarray
author
studi
way
minim
pcr
bia
ensur
uniform
amplif
develop
uniqu
statist
approach
infer
pathogen
ident
result
microarray
fingerprint
apart
highdens
microarray
describ
focus
biodef
platform
develop
select
panel
environment
bloodborn
pathogen
use
inhous
microarray
compris
sever
hundr
relev
probe
panel
design
select
identifi
target
interest
enough
redund
reduc
occurr
fals
posit
infrequ
control
diagnost
platform
often
use
either
one
hand
primer
set
specif
pathogen
interest
case
genexpert
rapid
cepheid
real
time
pcr
platform
sever
instruct
exampl
dna
microarray
advanc
understand
diseas
etiolog
epidemiolog
use
studi
molecular
evolut
hostpathogen
interact
mode
virul
follow
section
review
salient
studi
provid
fundament
insight
focus
agent
cdc
categori
c
one
import
applic
microarray
resequenc
pathogen
genom
success
appli
interrog
interspeci
andor
interstrain
differ
figur
provid
vital
altern
tradit
shotgun
sequenc
approach
quicker
costeffect
howev
disadvantag
sequenc
inform
organ
interest
must
avail
beforehand
sever
limit
given
mani
pathogen
organ
sequenc
advanc
de
novo
sequenc
capabl
new
pathogen
sar
readili
sequenc
matter
week
time
discoveri
subsequ
resequenc
use
microarray
would
take
sever
day
earli
experi
resequenc
array
show
high
rate
fals
discoveri
experiment
improv
develop
robust
algorithm
abacu
adapt
background
genotyp
call
scheme
softwar
packag
greatli
improv
sequenc
qualiti
adopt
approach
variat
analysi
wong
colleagu
track
strain
sar
coronaviru
rapidli
resequenc
use
highdens
microarray
total
probe
design
cover
complet
kb
genom
nimblegen
microarray
viru
sampl
cell
cultur
patient
tissu
could
amplifi
reversetranscriptas
pcr
use
optim
primer
resequenc
accuraci
greater
platform
use
confirm
lone
case
sar
viru
infect
graduat
student
like
come
laboratori
sourc
uniqu
delet
detect
present
sar
isol
wang
et
al
also
develop
sar
microarray
help
character
novel
coronaviru
variant
microarray
platform
thu
ideal
viru
track
outbreak
occur
furthermor
readili
applic
pathogen
evolutionari
perspect
lend
uniqu
insight
genet
chang
result
differ
pathogen
plaguecaus
pesti
estim
diverg
nonleth
yersinia
pseudotuberculosi
estim
year
ago
bear
ident
rrna
sequenc
comprehens
genet
analysi
requir
understand
differ
diseas
morbid
manifest
two
bacteri
speci
well
differ
mode
transmiss
human
pesti
flea
bite
pseudotuberculosi
food
water
microarray
specif
pesti
reveal
three
uniqu
genom
island
inactiv
sever
gene
includ
encod
celladhes
protein
adhesin
yada
invas
inv
well
oantigen
biosynthet
operon
uniqu
characterist
potenti
led
pesti
enhanc
virul
adapt
enter
organ
pseudotuberculosi
mammalian
bloodborn
pathogen
equival
find
report
hinchliff
et
al
use
similar
figur
use
microarray
studi
emerg
pathogen
exemplifi
sever
acut
respiratori
syndrom
sar
associ
coronaviru
avian
influenza
variou
approach
develop
detect
diagnost
dna
protein
microarray
specif
dna
probe
instanc
cov
orang
sar
green
use
detect
presenc
pathogen
dna
rna
use
pcr
revers
transcriptas
rt
pcr
thu
enabl
multipl
pathogen
detect
simultan
b
tile
array
use
resequ
pathogen
mutat
evolv
pathogen
rapidli
detect
track
illustr
four
probe
one
nucleotid
base
use
determin
genotyp
given
loci
set
probe
design
arbitrari
posit
xyz
shown
reveal
unknown
base
adenin
multipl
probe
set
tile
across
whole
pathogen
genom
upon
hybrid
analysi
confer
complet
sequenc
inform
pathogen
great
accuraci
c
antibodi
array
make
use
sandwich
immunoassay
screen
presenc
pathogen
depict
pathogen
sampl
first
appli
microarray
follow
report
antibodi
result
pathogen
sandwich
two
antibodiesan
immobil
antibodi
blue
tag
antibodi
purpl
capabl
report
presenc
pathogen
microarray
proteom
microarray
contain
immobil
protein
target
pathogen
screen
sera
obtain
infect
individu
individu
expos
pathogen
sera
contain
antibodi
blue
specif
antigen
pathogen
react
immobil
protein
detect
use
tag
secondari
antibodi
purpl
procedur
also
facilit
identif
specif
immunodomin
antigen
present
pathogen
proteom
protein
consid
larg
respons
trigger
host
immun
respons
thu
high
potenti
develop
vaccin
particular
pathogen
trend
biotechnolog
pesti
genespecif
microarray
also
show
three
major
pesti
subspeci
antiqua
mediaevali
biovar
show
greater
diverg
orientali
strain
similarli
variat
analysi
perform
burkholderia
pseudomallei
microarray
differenti
amongst
virul
avirul
burkholderia
speci
specif
bioterror
agent
b
pseudomallei
caus
meliodosi
b
mallei
caus
equin
glander
avirul
close
relat
b
thailandensi
interest
approach
reveal
molecular
mechan
pathogenesi
weiss
colleagu
develop
microarraybas
negativescreen
approach
francisella
obtain
surviv
bacteri
sampl
infect
mice
reveal
gene
respons
bacteri
surviv
growth
vivo
relat
studi
genomewid
microarray
also
reveal
loci
present
highli
virul
franscicella
tularensi
subspeci
tularensi
strain
loci
could
use
identifi
potenti
pathogen
island
well
provid
uniqu
genet
marker
could
use
strain
type
identif
microarray
also
appli
distinguish
among
variant
influenza
resist
antivir
drug
amantidin
detect
mutat
viral
ion
channel
protein
molecular
forens
experi
use
microarray
extend
capabl
profil
new
emerg
threat
differ
identifi
might
provid
understand
caus
increas
virul
well
reveal
vulner
exploit
build
therapeut
defenc
beyond
laboratorybas
applic
dna
microarray
test
success
epidem
outbreak
surveil
eo
project
silent
guardian
trial
launch
naval
research
laboratori
us
presidenti
inaugur
challeng
take
laboratorybas
microarray
technolog
productionscal
system
capabl
oper
screen
sampl
per
day
custom
dna
microarray
design
capabl
detect
natur
includ
avian
flu
biothreat
agent
strainlevel
resolut
total
sampl
collect
screen
civilian
militari
laboratori
personnel
within
stipul
period
trial
includ
blind
sampl
spike
pathogen
success
detect
exercis
showcas
feasibl
implement
microarray
screen
tool
eo
demonstr
use
rapid
robust
mean
sampl
process
pathogen
identif
recommend
studi
includ
develop
userfriendli
system
greater
autom
step
involv
featur
incorpor
sever
recent
launch
commerci
platform
microarraybas
platform
biothreat
screen
akonni
biosystem
http
wwwakonni
com
veredu
laboratori
http
wwwvereduslab
com
market
multiplex
threat
detect
new
advanc
includ
greater
integr
sampl
prepar
consid
one
major
bottleneck
ii
use
mpcr
iii
develop
small
handheld
microfluid
chip
portabl
reader
take
microarray
technolog
pointofcar
veredu
also
recent
launch
influenza
test
chip
enabl
amplif
discrimin
influenza
b
subtyp
includ
avian
flu
within
two
hour
great
improv
detect
time
attribut
mpcr
step
rapid
thermocycl
significantli
reduc
durat
pcr
min
similar
devic
might
develop
futur
protein
type
nondna
microarray
applic
serodiagnost
nation
institut
allergi
infecti
diseas
niaid
j
craig
venter
institut
fund
programm
enabl
research
obtain
approv
process
materi
transfer
agreement
mta
pathogen
dna
microarray
select
categori
ac
threat
cost
promot
acceler
research
pathogen
pathogen
function
genom
resourc
centr
pfgrc
current
fabric
distribut
rang
microarray
cover
agent
includ
b
anthraci
coronavirus
f
tularensi
pesti
b
pseudomallei
http
pfgrctigrorg
tabl
collabor
valuabl
initi
augur
favour
futur
biodef
commun
worldwid
hope
lead
greater
share
resourc
pursuit
knowledg
global
region
pathogen
emerg
role
protein
peptid
carbohydr
microarray
newer
microarray
format
alreadi
significantli
extend
scope
microarray
applic
advantag
parallel
miniatur
autom
hold
true
whichev
biomolecul
present
highdens
microarray
initi
difficult
believ
protein
would
retain
function
anchor
solid
support
howev
schreiber
colleagu
eras
concern
develop
first
smallmolecul
microarray
first
protein
microarray
simultan
demonstr
protein
could
retain
activ
despit
coval
attach
glass
slide
soon
afterward
array
type
develop
cell
array
carbohydr
array
proteom
array
newer
applic
brought
vital
capabl
pathogen
detect
biodef
describ
exampl
provid
key
biothreat
agent
categor
accord
consequ
applicationseith
detect
profil
pathogen
detect
use
nondnabas
microarray
antibodi
becom
establish
denomin
diseas
detect
timehonour
use
enzymelink
immunosorb
assay
elisa
agglutin
lateralflow
assay
nextgener
tool
antibodi
microarray
increas
popular
without
reason
offer
unparallel
throughput
minim
reagent
consumpt
sensit
detect
multipl
target
simultan
accuraci
confer
nevertheless
close
link
qualiti
review
trend
biotechnolog
vol
antibodi
employ
issu
relat
crossreact
antibodi
avail
particularli
crucial
finer
accur
strain
type
notwithstand
matter
plethora
antibodi
microarray
develop
grow
potenti
clinic
biothreat
pointofcar
applic
figur
rucker
et
al
appli
antibodi
microarray
detect
toxin
lownanomolar
sensit
anthrax
lethal
factor
lf
metalloendopeptidas
protect
antigen
pa
tetanu
toxin
endopeptidas
coapplic
competit
fluorescentlylabel
toxin
report
set
sampl
test
without
need
label
monitor
deplet
competit
displac
report
signal
gener
label
report
thirtyf
antibodi
also
array
subtyp
common
salmonella
serovar
similar
studi
undertaken
escherichia
coli
impress
demonstr
detect
throughput
attain
huelseweh
colleagu
built
antibodi
microarray
detect
sever
categori
b
agent
simultan
includ
f
tularensi
pesti
brucella
melitensi
caus
brucellosi
b
mallei
use
sandwich
immunoassay
figur
convers
antigen
microarray
also
use
identifi
seroposit
individu
use
presenc
defens
antibodi
serum
mean
detect
exposur
pathogen
pathogen
protein
typic
ortholog
express
use
highthroughput
clone
express
affin
purifi
provid
protein
set
special
case
might
necessari
consid
posttransl
modif
way
pathogen
present
host
identifi
use
correct
immunogen
protein
variant
serodiagnost
also
desir
purifi
protein
check
effici
gener
uniform
immobil
microarray
qualiti
control
especi
comparison
made
across
slide
one
exampl
sundaresh
et
al
narrow
initi
panel
f
tularensi
antigen
top
term
abil
predict
discrimin
seroposit
sera
use
antigen
establish
diagnost
microarray
compris
whole
protein
mezzasoma
et
al
also
develop
protein
microarray
simultan
diagnost
use
parasit
viral
antigen
zhu
et
al
monitor
antibodi
profil
sar
patient
use
protein
microarray
contain
purifi
coronaviru
protein
antibodi
present
human
serum
sampl
detect
protein
microarray
fluoresc
label
goat
antihuman
immunoglobulin
found
immunoreact
coronaviru
nucleocapsid
protein
remain
high
day
post
infect
provid
mean
check
exposur
long
infect
might
occur
human
sera
sampl
screen
accuraci
differenti
infect
normal
specimen
nevertheless
caution
appli
proteinbas
diagnost
incub
period
vari
greatli
amongst
diseas
incub
period
patient
might
express
antibodi
detect
level
might
still
capabl
spread
infect
case
sar
incub
period
time
exposur
onset
symptom
median
day
maximum
day
antibodi
might
detect
day
first
symptom
present
pcr
test
might
abl
pick
viru
quickli
day
symptom
becom
appar
might
becom
possibl
futur
integr
dnaand
proteinbas
microarray
method
extend
rang
rapid
clinic
diagnost
detect
current
pathogen
infect
test
exposur
long
actual
infect
occur
altern
short
peptid
also
appli
serodiagnost
facilit
robust
routin
procedur
establish
chemic
synthes
peptid
sequenc
amino
acid
length
peptid
microarray
appli
detect
immunoreact
sera
sar
amongst
pathogen
enabl
detect
lowpicomolar
concentr
antibodi
lipopolysaccharid
carbohydratebas
wholecel
microarray
also
use
antibodybas
detect
pathogen
f
tularensi
b
anthraci
b
pseudomallei
surfac
antigen
microb
frequent
respons
immunoreact
method
reli
detect
presenc
immunogen
antigen
improv
fabric
techniqu
greater
knowledg
surfac
chemistri
might
lead
develop
hybrid
microarray
platform
multipl
type
antigen
peptid
protein
carbohydr
present
simultan
detect
host
antibodi
improv
effici
sensit
pathogen
profil
use
nondnabas
microarray
protein
microarray
high
pathogen
proteom
content
offer
valuabl
platform
highthroughput
serolog
protein
immunoreact
patient
sera
repres
antigen
appli
marker
serodiagnost
therapeut
protein
vaccin
develop
one
exampl
immunogen
epitop
sar
coronaviru
trace
ctermin
fragment
nucleocapsid
protein
screen
human
sera
sampl
infect
individu
figur
address
bottleneck
protein
express
davi
colleagu
appli
pcr
recombin
clone
acceler
process
clone
express
enabl
protein
vaccinia
viru
protein
f
tularensi
express
profil
use
microarray
array
also
help
identifi
antibodi
vaccinia
viru
envelop
protein
confer
protect
vivo
mous
model
vaccinia
protein
microarray
also
use
deriv
antibodi
profil
human
inocul
licenc
dryvax
smallpox
vaccin
profil
found
similar
induc
attenu
modifi
vaccinia
viru
ankara
strain
altern
vaccin
candid
variou
protein
microarray
similarli
gener
identif
immunodomin
antigen
pesti
trend
biotechnolog
vol
microarray
platform
demonstr
valuabl
potenti
biodef
instanc
smallmolecul
microarray
appli
function
screen
anthrax
lf
activitybas
bind
signatur
librari
immobil
peptidehydroxam
inhibitor
put
drug
candid
discov
bound
select
anthrax
lf
low
dissoci
constant
k
mm
inhibit
activ
vitro
carbohydr
microarray
also
develop
elucid
receptor
prefer
influenza
virus
steven
colleagu
appli
glycan
array
establish
bind
select
haemagglutinin
determin
influenza
virul
select
alter
specif
mutat
protein
provid
use
way
function
monitor
viral
adapt
nondna
microarray
format
thu
contribut
uniqu
way
explor
pathogen
biolog
develop
countermeasur
event
outbreak
clear
microarray
significantli
strengthen
biodef
capabl
although
upstream
cost
librari
creation
microarray
fabric
well
initi
infrastructur
invest
sever
hundr
thousand
dollar
microarray
spotter
scanner
might
repres
signific
hurdl
small
laboratori
tight
budget
provis
print
microarray
slide
commerci
research
avenu
herald
favour
trend
toward
reduct
exclus
greater
access
technolog
increas
avail
microarray
togeth
establish
array
design
help
research
worldwid
move
quickli
toward
downstream
applic
phase
exampl
perform
region
studi
endem
variant
applic
microarray
describ
broadrang
span
dnaor
proteinbas
detect
pathogen
epidem
outbreak
surveil
vaccin
develop
thu
showcas
full
spectrum
microarray
potenti
tabl
progress
made
past
sever
year
brought
microarray
forefront
rapid
diagnost
medic
research
integr
upstream
sampl
prepar
downstream
data
process
expect
transform
microarray
compact
field
expedi
solut
analysi
monitor
near
futur
larg
assort
biomolecul
util
microarray
provid
novel
opportun
molecular
forens
compar
profil
especi
newer
less
wellunderstood
pathogen
equip
better
capabl
countermeasur
potenti
biolog
threat
hope
becom
agil
respons
whenev
threat
emerg
futur
microarray
improv
confid
respect
continu
play
decis
part
biodef
research
technolog
